Narasimhan: Novartis' Specialized Portfolio Will Lead To Bigger Breakthroughs And Greater Value

At Novartis’s first R&D day since he took the helm, new CEO Vas Narasimhan told Scrip about how the company plans to build value through its newly acquired breakthrough technologies and what deals it is looking for next.